BR9810930A - Pharmaceutical compositions of arglabine and arglabine derivatives - Google Patents

Pharmaceutical compositions of arglabine and arglabine derivatives

Info

Publication number
BR9810930A
BR9810930A BR9810930-8A BR9810930A BR9810930A BR 9810930 A BR9810930 A BR 9810930A BR 9810930 A BR9810930 A BR 9810930A BR 9810930 A BR9810930 A BR 9810930A
Authority
BR
Brazil
Prior art keywords
arglabine
derivatives
pharmaceutical compositions
compositions
effective
Prior art date
Application number
BR9810930-8A
Other languages
Portuguese (pt)
Inventor
Sergazy M Adekenov
Original Assignee
Paracure Inc Doing Business As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/934,229 external-priority patent/US5902809A/en
Application filed by Paracure Inc Doing Business As filed Critical Paracure Inc Doing Business As
Priority claimed from PCT/US1998/007989 external-priority patent/WO1998048789A1/en
Publication of BR9810930A publication Critical patent/BR9810930A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: <B>"COMPOSIçõES FARMACêUTICAS DE ARGLABINA E DERIVADOS DE ARGLABINA"<D>. São descritas composições farmacêuticas contendo arglabina e derivados de arglabina. As composições podem ser em forma de dosagem por unidade e são úteis para o tratamento de câncer em ser humano. São também descritos composições e kits contendo um primeiro agente quimioterapêutico que inclui arglabina ou um seu derivado e um segundo agente quimioterapêutico. As composições e os kits são eficazes para o tratamento de câncer em um paciente humano. A invenção também provê vários derivados de arglabina, eficazes para supressão de crescimento de tumor em mamíferos.Invention Patent: <B> "PHARMACEUTICAL COMPOSITIONS OF ARGLABINE AND ARGLABINE DERIVATIVES" <D>. Pharmaceutical compositions containing arglabine and arglabine derivatives are described. The compositions can be in unit dosage form and are useful for the treatment of cancer in humans. Compositions and kits containing a first chemotherapeutic agent that includes arglabine or a derivative thereof and a second chemotherapeutic agent are also described. The compositions and kits are effective for treating cancer in a human patient. The invention also provides several arglabine derivatives, effective for suppressing tumor growth in mammals.

BR9810930-8A 1997-04-26 1998-04-22 Pharmaceutical compositions of arglabine and arglabine derivatives BR9810930A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KZ970397 1997-04-26
US5168197P 1997-07-03 1997-07-03
US93422897A 1997-09-19 1997-09-19
US08/934,229 US5902809A (en) 1997-07-03 1997-09-19 Arglabin compounds and therapeutic uses thereof
PCT/US1998/007989 WO1998048789A1 (en) 1997-04-26 1998-04-22 Pharmaceutical compositions of arglabin and arglabin derivatives

Publications (1)

Publication Number Publication Date
BR9810930A true BR9810930A (en) 2000-09-26

Family

ID=27483548

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810930-8A BR9810930A (en) 1997-04-26 1998-04-22 Pharmaceutical compositions of arglabine and arglabine derivatives

Country Status (1)

Country Link
BR (1) BR9810930A (en)

Similar Documents

Publication Publication Date Title
DE69521994D1 (en) COMPOSITIONS WHICH CONTAIN DNA DESTROYING AGENTS AND P53
BR9715022A (en) Method for treating prostate disease using systematic and / or prolonged release of vitamin D formulations
BG101118A (en) Therapeutical compounds
ID29393A (en) COMPOSITION OF CANCER TREATMENT AND METHOD OF USING NATURAL PLANT ESENSIL OILS
BR0012136A (en) Highly selective norepinephrine reabsorption inhibitors and methods of using them
BR0110420A (en) Muscarinic Agonists
NO974694L (en) Pharmaceutical preparation containing N-phosphonoglycine derivatives to inhibit cancer and virus growth
BR9908510A (en) Use of a compound, compound, process for preparing a compound, pharmaceutical composition, and process for treating a patient suffering from, or at risk for, a mycobacterial disease
BR9813318A (en) Process of treating tumors and macular degeneration in a human or veterinary patient, pharmaceutical composition for treating tumors and macular degeneration in a human or veterinary patient
BR0010531A (en) Compositions and uses of et743 for cancer treatment
BR9814419A (en) &#34;combination of benzocycloheptapyridine compounds and antineoplastic drugs for the treatment of proliferative diseases&#34;
DE69637178D1 (en) N-CHLOROPHENYL CARBAMATE-CONTAINING MEDICAMENT AND N-CHLOROPHENYL THIOCARBAMATE TO INHIBIT THE GROWTH OF VIRUSES
BR0108728A (en) Pharmaceutical Combination Therapy, and, Method for Treating a Cancer.
WO2003017939A3 (en) Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment
BR9916432A (en) Triazinone compounds for the treatment of diseases due to sarcosystis, neospora and toxoplasma
NO983177L (en) Use of the 1-enantiomer of centroman for the preparation of a pharmaceutical composition for the treatment or prophylaxis of breast cancer
AP9801286A0 (en) Therapeutic compounds.
ATE199641T1 (en) TERPENDERIVATES (SARCODICTYINES) AS ANTI-CANCER AGENT
MX9203361A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING GALIUM CHLORIDE.
BR0214564A (en) Cancer Treatment Processes Using a Fpt Inhibitor and Antineoplastic Agents
BR9810930A (en) Pharmaceutical compositions of arglabine and arglabine derivatives
BR0015121A (en) Pharmaceutical composition usable for the treatment of inflammation in humans, and method of treating inflammation
HK1012242A1 (en) Topical composition containing penciclovir
MC2450A1 (en) Composition for the topical treatment of affections of the skin and appendages
ITRM940505A0 (en) &#34;ACTIVE AGENT FOR THE TREATMENT OF CHRONIC IMMUNODEPRESSION INFECTIONS AND TO CONTRAST THE DEVELOPMENT OF TUMORS FAVORIZED BY IMMUNODEPRESSION&#34;.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A, 7A,8A E 9A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007.